Dydrogesterone

Especificaciones

152-62-5Número CAS

205-806-8Número CE

(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-oneNombre IUPAC

C21H28O2Fórmula química

312.4 g/molPeso molecular

dydrogesterone; 152-62-5; Isopregnenone; Hydrogesterone; Duphaston; Gynorest; Hydrogestrone; Gestatron; Retrone; Diphaston; Dufaston; Duvaron; Terolut; Prodel; 10alpha-Isopregnenone; Retro-6-dehydroprogesterone; Didrogesterone; Dydrogesteronum; delta(6)-Retroprogesterone; didrogesterona; 6-Dehydro-retro-progesterone; delta(sup 6)-Retroprogesterone; 9beta,10alpha-Pregna-4,6-diene-3,20-dione; Retroprogesterone, 6-dehydro-; DTXSID1022974; NSC-92336; 6-Dehydro-9beta,10alpha-progesterone; (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; 90I02KLE8K; (9-beta,10-alpha)-Pregna-4,6-diene-3,20-dione; Pregna-4,6-diene-3,20-dione, (9beta,10alpha)-; 9-beta,10-alpha-Pregna-4,6-diene-3,20-dione; DTXCID702974; CHEBI:31527; Dehydrogesterone; NSC92336; 6-Dehydro-9 beta-10 alpha-progesterone; dibrogesterone; 6 Dehydro 9 beta 10 alpha progesterone; Duphaston-hrt; (1R,2S,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-6,8-dien-5-one; (1R,2S,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,8-dien-5-one; (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthren-3-one; RefChem:57304; G03DB01; 205-806-8; Didrogesterone [DCIT]; Dydrogesteronum [INN-Latin]; Dydrogesterona [INN-Spanish]; 6-Dehydroretroprogesterone; (9beta,10alpha)-pregna-4,6-diene-3,20-dione; MLS002153947; (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; Dydrogesterona; NSC 92336; Duphaston (TN); Gynorest (TN); (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; CAS-152-62-5; CCRIS 9069; HSDB 3321; MLS002695106; EINECS 205-806-8; 9-beta,10alpha-Pregna-4,6-diene-3,20-dione; UNII-90I02KLE8K; Dydrogesterone; 9beta,10alpha-Pregna-4,6-diene-3,20-dione; Dydrogesterone?; Dydrogesterone CRS; NCGC00016413-01; MFCD00867864; Dydrogesterone [USAN:USP:INN:BAN:JAN]; 6-Dehydro-9.beta.,10.alpha.-progesterone; Prestwick0_000671; Prestwick1_000671; Prestwick2_000671; Prestwick3_000671; Dydrogesterone (Standard); DYDROGESTERONE [MI]; Pregna-4,6-diene-3,20-dione, (9b,10a)-; .DELTA.6-Retroprogesterone; DYDROGESTERONE [INN]; DYDROGESTERONE [JAN]; SCHEMBL37703; BSPBio_000761; DYDROGESTERONE [HSDB]; DYDROGESTERONE [USAN]; SPBio_002682; DYDROGESTERONE [MART.]; BPBio1_000839; GTPL2878; HY-B0257AR; orb1304602; Pregna-4,6-diene-3,20-dione, (9-beta,10-alpha)-; DYDROGESTERONE [USP-RS]; DYDROGESTERONE [WHO-DD]; CHEMBL1200853; HY-B0257A; 9.beta.,6-diene-3,20-dione; MSK8567; Dydrogesterone (JP18/USP/INN); HMS1570G03; HMS2097G03; HMS2230C10; HMS3714G03; 9-.beta.,6-diene-3,20-dione; DYDROGESTERONE [ORANGE BOOK]; Tox21_110429; DYDROGESTERONE [EP MONOGRAPH]; EBC-26745; MSK8567-100M; s4097; DYDROGESTERONE [USP MONOGRAPH]; AKOS015895532; Tox21_110429_1; CCG-220671; DB00378; FD22631; GS-6735; NCGC00179445-01; NCGC00179445-03; NCGC00179445-04; (1S,3aS,3bS,9aS,9bR,11aS)-1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; SMR001233286; SY392723; (9b,10a)-Pregna-4,6-diene-3,20-dione; AB00513884; NS00009687; T3036; D01217; Dydrogesterone Solution in Methanol, 100ug/mL; H10151; Pregna-4,20-dione, (9.beta.,10.alpha.)-; AB00513884_04; EN300-19767791; SR-01000841256; Q4161380; SR-01000841256-2; BRD-K68620903-001-03-1; BRD-K68620903-001-09-8; BRD-K68620903-001-11-4; PREGNA-4,6-DIENE-3,20-DIONE, (9.BETA.,10.ALPHA.)Sinónimos